tirzepatide weight loss results 12 weeks (zepbound) 12-Week Program at Bethany Clinic, NJ Tirzepatide weight loss transformation in

Again, just be sure to watch for additives

PLoS One , 13 (3), e0193801

Interventions Patients were randomized to receive once-weekly subcutaneous injections of the allocated tirzepatide (Eli Lilly and Company) or placebo treatment for 40 weeks, followed by a 4-week safety follow-up period (eFigure 1 in Supplement 2)

Their principal advantages include dose-dependent estrogen suppression, fast reversibility of hormone secretion after treatment cessation, oral delivery, and avoidance of the flare-up effect

It enhances blood sugar control by increasing insulin release, reducing liver glucose output, and slowing gastric emptying